EG17673A - Improved inflamatory salts of piroxicam - Google Patents
Improved inflamatory salts of piroxicamInfo
- Publication number
- EG17673A EG17673A EG645/85A EG64585A EG17673A EG 17673 A EG17673 A EG 17673A EG 645/85 A EG645/85 A EG 645/85A EG 64585 A EG64585 A EG 64585A EG 17673 A EG17673 A EG 17673A
- Authority
- EG
- Egypt
- Prior art keywords
- piroxicam
- salts
- sub
- improved
- inflamatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/659,733 US4567179A (en) | 1984-10-11 | 1984-10-11 | Antiinflammatory salts of piroxicam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG17673A true EG17673A (en) | 1990-08-30 |
Family
ID=24646598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG645/85A EG17673A (en) | 1984-10-11 | 1985-10-10 | Improved inflamatory salts of piroxicam |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4567179A (xx) |
| EP (1) | EP0178124B1 (xx) |
| JP (1) | JPS6193182A (xx) |
| KR (1) | KR870000277B1 (xx) |
| CN (1) | CN1008062B (xx) |
| AT (1) | ATE44147T1 (xx) |
| AU (1) | AU553819B2 (xx) |
| CA (1) | CA1240323A (xx) |
| DD (1) | DD237658A5 (xx) |
| DE (1) | DE3571132D1 (xx) |
| DK (1) | DK463385A (xx) |
| EG (1) | EG17673A (xx) |
| FI (1) | FI82044C (xx) |
| GR (1) | GR852457B (xx) |
| HU (1) | HU193348B (xx) |
| IE (1) | IE58722B1 (xx) |
| IL (1) | IL76644A0 (xx) |
| NO (1) | NO854033L (xx) |
| NZ (1) | NZ213743A (xx) |
| PH (1) | PH21594A (xx) |
| PL (1) | PL255696A1 (xx) |
| PT (1) | PT81279B (xx) |
| SU (1) | SU1375136A3 (xx) |
| YU (1) | YU44897B (xx) |
| ZA (1) | ZA857785B (xx) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4812455A (en) * | 1984-10-11 | 1989-03-14 | Pfizer Inc. | Antiinflammatory compositions and methods |
| US5260333A (en) * | 1986-08-08 | 1993-11-09 | Bristol Myers Squibb Company | Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| EP1169322B8 (en) | 1999-03-08 | 2006-09-13 | Medicure Inc. | Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6 |
| AU5840200A (en) | 1999-07-13 | 2001-01-30 | Medicure Inc. | Treatment of diabetes and related pathologies |
| EP1872797A3 (en) | 1999-08-24 | 2008-04-02 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
| US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| WO2001064692A1 (en) | 2000-02-29 | 2001-09-07 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| US6586414B2 (en) | 2000-03-28 | 2003-07-01 | Medicure International Inc. | Treatment of cerebrovascular disease |
| ATE364595T1 (de) | 2000-07-07 | 2007-07-15 | Medicure Int Inc | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika |
| US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
| US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
| US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
| US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
| JP2008505126A (ja) * | 2004-07-07 | 2008-02-21 | メディキュア インターナショナル インコーポレイテッド | 血小板凝集薬を用いる併用療法 |
| US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
| US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
| CA2585165A1 (en) * | 2004-10-28 | 2006-05-18 | Medicure International Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
| US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
| CA2632090A1 (en) * | 2005-11-28 | 2007-05-31 | Medicure International Inc. | Selected dosage for the treatment of cardiovascular and related pathologies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230717A (en) * | 1978-12-29 | 1980-10-28 | Lovelace Alan M Administrator | Indomethacin-antihistamine combination for gastric ulceration control |
| US4374843A (en) * | 1980-10-14 | 1983-02-22 | Pfizer Inc. | 2-Guanidino-4-heteroarylthiazoles |
| US4434163A (en) * | 1981-06-01 | 1984-02-28 | Pfizer Inc. | Water-soluble benzothiazine dioxide salts |
| GB2105193B (en) * | 1981-09-04 | 1984-09-12 | Glaxo Group Ltd | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
| BE894286A (fr) * | 1981-09-04 | 1983-03-02 | Glaxo Group Ltd | Composition pharmaceutique contenant un medicament anti-inflammatoire systemique non steroidique et du 1-methyl-5-((3-(3-(1-piperidinylmethyl)phenoxy)-propyl)amino -1h-1,2,4-triazole-3-methanol ou un sel de ce compose |
-
1984
- 1984-10-11 US US06/659,733 patent/US4567179A/en not_active Expired - Fee Related
-
1985
- 1985-10-02 EP EP85307059A patent/EP0178124B1/en not_active Expired
- 1985-10-02 AT AT85307059T patent/ATE44147T1/de not_active IP Right Cessation
- 1985-10-02 DE DE8585307059T patent/DE3571132D1/de not_active Expired
- 1985-10-08 NZ NZ213743A patent/NZ213743A/xx unknown
- 1985-10-09 GR GR852457A patent/GR852457B/el unknown
- 1985-10-09 PT PT81279A patent/PT81279B/pt unknown
- 1985-10-09 ZA ZA857785A patent/ZA857785B/xx unknown
- 1985-10-09 CA CA000492570A patent/CA1240323A/en not_active Expired
- 1985-10-09 PL PL25569685A patent/PL255696A1/xx unknown
- 1985-10-10 CN CN85107498A patent/CN1008062B/zh not_active Expired
- 1985-10-10 EG EG645/85A patent/EG17673A/xx active
- 1985-10-10 SU SU853971352A patent/SU1375136A3/ru active
- 1985-10-10 KR KR1019850007443A patent/KR870000277B1/ko not_active IP Right Cessation
- 1985-10-10 YU YU1616/85A patent/YU44897B/xx unknown
- 1985-10-10 PH PH32915A patent/PH21594A/en unknown
- 1985-10-10 AU AU48484/85A patent/AU553819B2/en not_active Ceased
- 1985-10-10 DD DD85281614A patent/DD237658A5/de not_active IP Right Cessation
- 1985-10-10 DK DK463385A patent/DK463385A/da not_active Application Discontinuation
- 1985-10-10 IL IL76644A patent/IL76644A0/xx not_active IP Right Cessation
- 1985-10-10 IE IE249885A patent/IE58722B1/en not_active IP Right Cessation
- 1985-10-10 FI FI853946A patent/FI82044C/fi not_active IP Right Cessation
- 1985-10-10 HU HU853940A patent/HU193348B/hu not_active IP Right Cessation
- 1985-10-10 NO NO854033A patent/NO854033L/no unknown
- 1985-10-11 JP JP60226663A patent/JPS6193182A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG17673A (en) | Improved inflamatory salts of piroxicam | |
| NO851623L (no) | Borefluid. | |
| DE3578981D1 (de) | 2,6-substituierte pyridinverbindungen. | |
| DE3484157D1 (de) | 2,6-substituierte pyridinverbindungen. | |
| NO162970C (no) | Borevaeske. | |
| DE3577345D1 (de) | Hydrostatische hydraulik-kupplung. | |
| DE3874903D1 (de) | Substituierte 2,6-substituierte pyridin-verbindungen. | |
| DE3887357D1 (de) | Substituierte 2,6-substituierte Pyridin-Verbindungen. | |
| NO851670L (no) | Borevaeske. | |
| DE3577031D1 (de) | Pflug. | |
| ATE71379T1 (de) | 2-phenylpyrano(2,3-b>pyridine. | |
| FI855121A0 (fi) | Kopplingsanordning foer kommunikationsanlaeggningar, saerskilt telefonanlaeggningar, med till foermedlingsstaellen via ledningsknippen anslutna underfoermedlingsstaellen. | |
| ATE55124T1 (de) | 2,6-substituierte pyridinverbindungen. | |
| GB2162773B (en) | Boring head, e.g. for forming non-circular holes | |
| NO153719C (no) | Formingsverktoey, spesielt dyptrekkingsverktoey. | |
| ATE43596T1 (de) | 6-substituierte penicillansaeure-1,1-dioxydverbindungen. | |
| IT8433319V0 (it) | Spiralex maxima securitas 2000 n. 5cu 285,70 mg | |
| FI842797A0 (fi) | Synkroniserad, hydrostatisk-mekanisk vaexellaoda. | |
| IT8433323V0 (it) | Spiralex maxima securitas 2000 n. 3cu 213,33 mg. | |
| ATE100806T1 (de) | Substituierte 2,6-substituierte pyridinverbindungen. | |
| ATE81124T1 (de) | Substituierte 2,6-substituierte pyridinverbindungen. | |
| ATE61048T1 (de) | 2,6-substituierte pyridinverbindungen. | |
| FI855122A (fi) | Kopplingsanordning foer kommunikationsanlaeggningar, saerskilt telefonanlaeggningar, med till foermedlingsstaellen via ledningsknippen anslutna underfoermedlingsstaellen. | |
| ATE65151T1 (de) | Drillmaschine. | |
| IE843061L (en) | Pyridone derivatives, h2-antagonists |